Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hair follicle keratin may have been used in tooth enamel evolution.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride may help prevent prostate cancer.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Higher serum androgens contribute to male pattern baldness.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Finasteride for hair loss may cause painless bleeding in urine and semen.

Finasteride may reduce bleeding after TURP, but more research needed.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.